Re:course develops an AI-based platform for clinical and life sciences patient communication assistance and healthcare education.
Re:course has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in February 2023.
Re:course's investors include Northern Gritstone, Praetura Ventures, Par Equity, Aerion Partners, SBRI Healthcare.
Re:course is headquartered in Manchester, United Kingdom.
Re:course develops an AI-based platform for clinical and life sciences patient communication assistance and healthcare education.
Re:course is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Re:course — Funding & Investors." VCBacked, February 2, 2023, https://www.vcbacked.co/company/recourse. Accessed August 14, 2026.
VCBacked. (2023). Re:course — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/recourse
{{cite web |title=Re:course — Funding & Investors |url=https://www.vcbacked.co/company/recourse |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated